108 related articles for article (PubMed ID: 6881330)
41. A role for pancreatic polypeptide in the regulation of gastric emptying and short-term metabolic control.
Schmidt PT; Näslund E; Grybäck P; Jacobsson H; Holst JJ; Hilsted L; Hellström PM
J Clin Endocrinol Metab; 2005 Sep; 90(9):5241-6. PubMed ID: 15998783
[TBL] [Abstract][Full Text] [Related]
42. Pancreatic hormones in streptozotocin-diabetic rats.
Tomita T; Sasaki S; Doull V; Bunag R; Kimmel JR
Int J Pancreatol; 1986 Oct; 1(3-4):265-78. PubMed ID: 2890693
[TBL] [Abstract][Full Text] [Related]
43. Splanchnic and renal contribution to disposal of infused epinephrine in humans.
Saccà L; Hendler R; Picardi A; Sherwin RS
Am J Physiol; 1986 Sep; 251(3 Pt 1):E285-9. PubMed ID: 3752240
[TBL] [Abstract][Full Text] [Related]
44. Evidence for vagus-dependent pancreatic polypeptide-releasing factor in the antrum: studies with the autotransplanted dog pancreas.
Debas HT; Taylor IL; Seal AM; Passaro EP
Surgery; 1982 Aug; 92(2):309-14. PubMed ID: 7048599
[TBL] [Abstract][Full Text] [Related]
45. In vivo pulsatility of pancreatic islet peptides.
Jaspan JB; Lever E; Polonsky KS; Van Cauter E
Am J Physiol; 1986 Aug; 251(2 Pt 1):E215-26. PubMed ID: 2874743
[TBL] [Abstract][Full Text] [Related]
46. Clearance of atrial natriuretic factor by lung, liver, and kidney in human subjects and the dog.
Hollister AS; Rodeheffer RJ; White FJ; Potts JR; Imada T; Inagami T
J Clin Invest; 1989 Feb; 83(2):623-8. PubMed ID: 2521490
[TBL] [Abstract][Full Text] [Related]
47. Pancreatic polypeptide administration improves abnormal glucose metabolism in patients with chronic pancreatitis.
Brunicardi FC; Chaiken RL; Ryan AS; Seymour NE; Hoffmann JA; Lebovitz HE; Chance RE; Gingerich RL; Andersen DK; Elahi D
J Clin Endocrinol Metab; 1996 Oct; 81(10):3566-72. PubMed ID: 8855802
[TBL] [Abstract][Full Text] [Related]
48. Metabolism in immunoreactive parathyroid hormone in the dog. The role of the kidney and the effects of chronic renal disease.
Hruska KA; Kopelman R; Rutherford WE; Klahr S; Slatopolsky E; Greenwalt A; Bascom T; Markham J
J Clin Invest; 1975 Jul; 56(1):39-48. PubMed ID: 1141439
[TBL] [Abstract][Full Text] [Related]
49. The in vivo metabolism of somatostatin 28: possible relationship between diminished metabolism and enhanced biological action.
Polonsky K; Jaspan J; Berelowitz M; Pugh W; Moossa A; Ling N
Endocrinology; 1982 Nov; 111(5):1698-703. PubMed ID: 6127205
[TBL] [Abstract][Full Text] [Related]
50. Contribution of the kidney to metabolic clearance of atrial natriuretic peptide.
Woods RL
Am J Physiol; 1988 Dec; 255(6 Pt 1):E934-41. PubMed ID: 2974242
[TBL] [Abstract][Full Text] [Related]
51. Fluctuations in basal plasma levels of pancreatic polypeptide in monkeys and humans.
Hansen BC; Jen KL; Pek SB; Wolfe RA
Am J Physiol; 1985 Jun; 248(6 Pt 2):R739-47. PubMed ID: 3890564
[TBL] [Abstract][Full Text] [Related]
52. Motilin is a biosignal controlling cyclic release of pancreatic polypeptide via the vagus in fasted dogs.
Mochiki E; Inui A; Satoh M; Mizumoto A; Itoh Z
Am J Physiol; 1997 Feb; 272(2 Pt 1):G224-32. PubMed ID: 9124345
[TBL] [Abstract][Full Text] [Related]
53. Factors influencing the handling of insulin by the isolated rat kidney.
Rabkin R; Kitabchi AE
J Clin Invest; 1978 Jul; 62(1):169-75. PubMed ID: 659630
[TBL] [Abstract][Full Text] [Related]
54. Pancreatic polypeptide regulates glucagon release through PPYR1 receptors expressed in mouse and human alpha-cells.
Aragón F; Karaca M; Novials A; Maldonado R; Maechler P; Rubí B
Biochim Biophys Acta; 2015 Feb; 1850(2):343-51. PubMed ID: 25445712
[TBL] [Abstract][Full Text] [Related]
55. Renal catabolism of truncated glucagon-like peptide 1.
Ruiz-Grande C; Alarcón C; Alcántara A; Castilla C; López Novoa JM; Villanueva-Peñacarrillo ML; Valverde I
Horm Metab Res; 1993 Dec; 25(12):612-6. PubMed ID: 8119664
[TBL] [Abstract][Full Text] [Related]
56. Comparison of the continuously calculated fractional splanchnic extraction of insulin with its fractional disappearance using a new double-tracer technique.
Pye S; Watarai T; Davies G; Radziuk J
Metabolism; 1993 Feb; 42(2):145-53. PubMed ID: 8474310
[TBL] [Abstract][Full Text] [Related]
57. Glucagon-like peptide 1 undergoes differential tissue-specific metabolism in the anesthetized pig.
Deacon CF; Pridal L; Klarskov L; Olesen M; Holst JJ
Am J Physiol; 1996 Sep; 271(3 Pt 1):E458-64. PubMed ID: 8843738
[TBL] [Abstract][Full Text] [Related]
58. Effects of changes in steady state plasma vasopressin levels on renal and urinary vasopressin clearances in the dog.
Matsui K; Share L; Wang BC; Crofton JT; Brooks DP
Endocrinology; 1983 Jun; 112(6):2107-13. PubMed ID: 6851941
[TBL] [Abstract][Full Text] [Related]
59. Plasma levels and renal removal of gastrin after acute hepatic ischemia in dogs.
Pezzarossa A; Contini S; Scarpignato C; Bairamian M; Coiro V; Butturini U
J Endocrinol Invest; 1984 Jun; 7(3):201-5. PubMed ID: 6470435
[TBL] [Abstract][Full Text] [Related]
60. Regional pharmacokinetics of amifostine in anesthetized dogs: role of the liver, gastrointestinal tract, lungs, and kidneys.
Levi M; Knol JA; Ensminger WD; DeRemer SJ; Dou C; Lunte SM; Bonner HS; Shaw LM; Smith DE
Drug Metab Dispos; 2002 Dec; 30(12):1425-30. PubMed ID: 12433814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
